Dose-Modified Ifosfamide, Epirubicin, and Etoposide is a Safe and Effective Salvage Therapy with High Peripheral Blood Stem Cell Mobilization Capacity for Poorly Mobilized Hodgkin’s Lymphoma and Non-Hodgkin’s Lymphoma Patients

A dose modified ifosfamide, epirubicin, and etoposide (IVE) regimen was prospectively assessed for its efficacy in mobilizing peripheral blood stem cells for autologous transplantation. Two patients with Hodgkin’s lymphoma and two with non-Hodgkin’s lymphoma who were undergoing stem cell therapy wer...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:J Clin Exp Hematop
Hauptverfasser: Fukunaga, Akiko, Hyuga, Mizuki, Iwasaki, Makoto, Nakae, Yoshiki, Kishimoto, Wataru, Maesako, Yoshitomo, Arima, Nobuyoshi
Format: Artigo
Sprache:Inglês
Veröffentlicht: JSLRT 2016
Schlagworte:
Original Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6144278/
https://ncbi.nlm.nih.gov/pubmed/27334858
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3960/jslrt.56.50
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge